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ABSTRACT 
Rats were injected with colchicine and the secretion of triglycerides into the serum 
was studied  for 90 min after injection of [14C]palmitic acid and Triton WR  1339. 
The release of labeled and chemically determined triglyceride was reduced to about 
20-30% of control values. The effect of colchicine on serum triglyceride levels was 
not dependent on the presence of Triton and was similar in males and females and 
in fed and fasted rats. The effect was dose dependent and was reversible 6-7 h after 
injection  of 0.05  mg/100 g  body weight.  Colchicine  inhibited  also the  release of 
labeled  proteins  into  the  serum  but  did  not  affect  the  amount  of  [3H]leucine 
incorporated  into liver proteins.  Within  4  h  of colchicine treatment there was an 
80% fall in serum very low density lipoproteins (VLDL), a 30% fall in serum high 
density  lipoproteins  (HDL),  and  no  change  in  the  d  >  1.21  protein  level,  but 
reduction  in  the  appearance  of  labeled  proteins  was  encountered  in  all  serum 
fractions. Colchicine had no effect on the rate of bile flow and on the secretion of 
phospholipids and cholesterol into the bile. In the hepatocyte there was accumula- 
tion  of Golgi-derived secretory vesicles, containing nascent VLDL particles; these 
vesicles were seen also in the vicinity of the sinusoidal cell surface, but the space of 
Disse contained  few or no  VLDL  particles.  There  was an  apparent  reduction  in 
microtubules  and  some  increase  in  microfilaments.  It  is  suggested  that  mi- 
crotubules  affect  the  secretion  of  lipoproteins  and  proteins  into  the  serum  by 
maintaining the organization  of the plasma membrane required  for its fusion with 
secretory vesicles. The lack of effect of colchicine on biliary lipid secretion indicates 
that the latter is not dependent on vesicular transport. 
INTRODUCTION 
The mammalian liver cell  secretes lipids  into the 
blood stream in the form of lipoproteins and into 
the bile in the form of lipid micelles. The intracel- 
lular  pathways  leading  to  the  secretion  of lipo- 
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extensively  (1  3);  however,  not  much  is  known 
about  the  regulation  of  the  final  steps,  i.e.  the 
transport of the secretory vesicles from the Golgi 
apparatus towards the sinusoidal cell surface and 
the release of the secretory products. Recently, we 
have examined the effect of agents known to affect 
the microtubular system on the release of very low 
density  lipoproteins (VLDL)  into  the  circulation 
and  have  shown that,  in  the rat,  colchicine inter- 
feres  with  the  secretion of these lipoproteins (4). 
Colchicine did not affect the synthesis of triglycer- 
ides  by  the  liver,  nor  did  it  cause  inhibition  of 
protein synthesis (4).  These  findings were further 
corroborated by others (5, 6) in the perfused mouse 
liver.  Presently,  information was  sought whether 
the  secretion of high  density lipoproteins (HDL) 
and  of  proteins  into  the  serum  as  well  as  of 
phospholipids and cholesterol into the bile is also 
affected by colchicine administration. An attempt 
was made also to define more closely the optimal 
conditions for studying the effects of colchicine on 
the  secretory  activity  of  rat  liver  in  the  intact 
animal. 
MATERIALS  AND  METHODS 
Animals and Experimental Procedure 
Female  and  male  200  g  albino  rats  of the  Hebrew 
University strain, fed the pelleted  diet Am Rod 931  (7) 
and  kept  in  constant temperature room, were  used.  In 
some experiments the  rats  were  given  10%  sucrose in 
drinking water for 5 days in order to raise serum VLDL 
levels. Colchicine (Sigma Chemical Co., St. Louis, Mo.) 
was dissolved  in 0.9% NaCI immediately before use and 
was injected intraperitoneally in a single dose of 0.05 or 
0.5  mg/100 g body weight.  The control rats were given 
0.9%  NaCI.  To  study  the  rate  of  secretion  of  liver 
triglycerides into the circulation, all rats received 1 ~Ci of 
[l-14C]palmitic  acid  (specific  activity  59  Ci/mol)  pre- 
pared as a sodium salt complexed to bovine albumin (8) 
followed  by 0.5 ml of 20% solution of Triton WR  1339 
(Serva,  Heidelberg,  Germany)  in  0.9% NaC1, injected 
into  an  exposed femoral vein.  The  rats were  killed  by 
exsanguination 90 rain thereafter. In order to study  the 
protein moiety of serum lipoproteins, female rats were 
injected  intraperitoneally with colchicine  (0.5 mg/100 g 
body weight)  and  180  min  later were  injected  intrave- 
nously  with  10-40  ~Ci  of  L-[4,5-~H]leucine  (specific 
activity  36 Ci/mmol). The rats were killed by exsangui- 
nation 60 min after injection  of leucine. Liver and serum 
proteins were isolated and purified according to Siekevitz 
(9). 
Vinblastine sulfate  (Eli  Lilly  and  Co.,  Indianapolis, 
Ind.)  0.1  or  1.0  rag/100  g  body  weight  was  injected 
intraperitoneally  and  was  followed  at  different  time 
intervals  by intravenous injections of [l-l~C]palmitic acid 
and Triton WR  1339. The rats were killed 90 min after 
injection  of the labeled  fatty acid. 
In  Vitro Study 
Liver slices, prepared with the help of a Stadie Riggs 
slicer,  were  incubated  in  Krebs-Ringer  bicarbonate 
buffer containing 0.5% bovine  serum  albumin  and  10 
mM  glucose  at  38°C  in  95%  02-5%  CO2  for  3  h. 
Vincristine  sulfate  (Eli  Lilly  and  Co.)  or  vinblastine 
sulfate  was added to  the incubation medium to give  a 
final concentration of 10 -5 or 10 _6  M. 
Isolation of Lipoprotein  Fractions 
In  several  experiments the sera of experimental and 
control rats were pooled and lipoproteins were isolated 
by ultracentrifugation according to Havel et al. (10) in a 
Spinco model  L265B ultracentrifuge (Beckman  Instru- 
ments, Inc., Spinco Div., Palo Alto, Calif.). 
VLDL were isolated at density 1.006 using a 50. I rotor 
at  192,000 g for 16 h. After isolation  by the tube slicing 
technique the  VLDL  were  washed  twice  at  density of 
1.006, using a SW41  rotor for  16 h at 201,000 g. After 
removal  of VLDL  the  serum  was  adjusted  to  density 
1.085 with  solid  KBr and centrifuged in Ti  50  rotor at 
150,000  g  for  24  h.  After  removal  of the  d  <1.085 
fraction  the  serum  was  adjusted  to  density  1.21  and 
centrifuged in SW41  rotor for 48  b at 201,000 g. The d 
< 1.21 fraction was isolated by tube slicing and refloated 
at d  1.21 for 48 h at 201,000 g; this fraction consisted of 
HDL,  which  proved to  be of uniform size on  negative 
staining. 
Chemical and Radiochemical Procedure 
Serum  and  liver  lipids  were  extracted  and  washed 
according to  Folch et al.  (11).  Samples of the purified 
chloroform extracts were taken for the determination of 
radioactivity  and  for  separation  into  lipid  classes  by 
thin-layer chromatography, using Silica GeI-G plates and 
a  solvent  system  consisting  of  petroleum  ether  (bp 
30-60°C)-diethylether-glacial acetic acid (80: 20: 1, vol/ 
vol/vol). The fractions, visualized  by iodine vapor, were 
identified with  the help of reference standards and the 
lipid classes were scraped into counting vials and assayed 
in a S-scintillation spectrometer (1). Serum triglycerides 
were  determined by  a  semiautomated procedure (12). 
5-10  mg  of the  purified  liver  and  serum  protein  was 
dissolved  in  0.5  ml  Soluene (Packard  Instrument Co., 
Inc.,  Downers  Grove,  Ill.)  and  the  radioactivity  was 
determined using  the  scintillation system consisting of 
toluene-dioxane-ethanol (5: 3: 2,  vol/vol/vol) and  0.4% 
2,5-diphenyloxazole and  0.015% dimethyl-  I, 4-bis-2-(4- 
methyl-5-phenyloxazolyl)benzol. All  radioactivity mea- 
surements  were  performed  with  the  Tri-Carb  liquid 
scintillation  spectrometer 3380, equipped with the abso- 
lute activity  analyzer, model 544. 
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Electron  Microscopy 
Liver was fixed in either 4% osmium tetroxide for 2 h 
at  0°C  or  in  half-strength  Karnovsky's  formaldehyde 
(prepared  from paraformaldehyde) glutaraldehyde fixa- 
tive (13)  for  1-2  h  followed  by  postfixation  with  2% 
osmium tetroxide  in  acetate-Veronal  buffer  (14).  The 
tissue was  then  subjected  to  either  partial  or  complete 
dehydration  (1)  and  embedded  in  Epon  (15).  Sections 
were  prepared  with  the  LKB  ultratome  using  glass 
knives, were stained with uranyl acetate and lead citrate 
(16),  and  examined  with  the  Philips  EM  300  electron 
microscope at 60 kV. 
Cannulation  of the  Bile  Duct 
Female  rats  weighing  220  250  g  were  used.  Under 
ether anesthesia a  Pe  10 polyethylene tube was tied into 
the proximal third  of the bile duct,  threaded  through a 
subcutaneous tunnel, and exteriorized in the interscapu- 
lar  region (17).  The  rats were  kept  in  restraining cages 
and had  access to  food and water.  After the first 2  h of 
bile  collection,  the  rats  were  injected  into  the tail  vein 
with colchicine 0.2 mg/100 g  body weight or with 0.9% 
NaCI.  Collection  of  bile  continued  for  two  additional 
periods of 2 h each. Aliquots of bile were extracted with 
chloroform-methanol 2: 1, and lipid phosphorus (18) and 
cholesterol  (19)  were  determined  on  the  chloroform 
extract. 
RESULTS 
The  present  experimental  design,  in  which  the 
removal of serum triglyceride was prevented by the 
administration  of Triton WR  1339 (20),  permitted 
US to  study the  rate  of secretion of lipoproteins  in 
the intact  rat.  The effect  of a  high and a  low dose 
of colchicine on the release of labeled triglycerides 
as  well  as  on  the  level  of chemically  determined 
triglycerides  in  the serum was studied in  male and 
female rats (Table  I),  and the'degree of inhibition 
in both  sexes was found not to differ significantly. 
However,  the  rate  of triglyceride  secretion  in  the 
control  rats  was  higher  in  the  female,  and  so the 
next  series  of  experiments  was  performed  on 
female rats. In non-Triton-treated  rats, injection of 
colcbicine  resulted  in  a  fall  of serum  triglyceride 
levels of the same magnitude observed in rats given 
Triton  (Table  I1). The duration  of effect of colchi- 
cine was  related  to  the dose  used (Table  III),  and 
with  the  low  dose  the  maximal  reduction  was 
observed  after  270 rain.  With 0.05  rag/100 g  body 
TABLE  II 
Effect of Colchicine  on Serum  Triglycerides  in 
Non- Triton- Treated  Rats 
Colchicine  Serum triglycerides in 
per 100g 
body  Sucrose  Purina 
weight  fed*  Change  fed  Change 
mg  mg/dl  %  mg/dl  % 
None  218 ~: 29  98±11 
0.05  104 ±  12  -52.3  54 ~ 8  -44.9 
0.50  55 ± 5  -75.0  -- 
Colchicine  was  injected  intraperitoneally  at  time  0  and  the 
experiment was terminated 270 min later. 
* Rats  supplemented  for  5  days  with  10%  sucrose  in  their 
drinking water. 
TABLE  I 
Effects of Colchicine  on Secretion of Serum  Triglycerides  in Female and Male Rats 
Serum lipids 
Colchicine 
per 100 g  ["C]Lipid  Triglyceride 
body weight  Sex  released*  Change  Content  Change 
mg  %  %  mg/dl~;  % 
None  F  48.0 ±  1.9  937 ±  30 
0.05  F  14.4 ±  0.7  -70.0  381  ±  38  -59.3 
0.50  F  7.7 ±  2.4  -84.0  336 ±  35  -64.2 
None  M  42.3 ±  7.8  540 ±  10 
0.05  M  18.5 ±  4.1  -56.3  253 ±  21  53.2 
0.50  M  10.2 ±  1.1  75.9  182 ±  18  -66.3 
Colchicine  was  injected  intraperitoneally  at  time  0  and  [l-x4C]palmitic  acid  and  Triton  WR  1339  were  injected 
intravenously at  180  min and the rats were killed at 270 min. Values are means ±SE of five to six rats. 
* [l'C]Lipid  released  [~4C]lipid  in serum  x  100;  in  serum  lipids  more  than  95%  of the  label  was  in 
triglyceride.  ['~C]lipid  in liver and serum 
:~dl  =  100ml. 
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found to be reversible; however, no reversibility up 
to  7  h  could  be  found  at  the  higher  dose  level 
(Table II I). Colchicine administration resulted in a 
similar inhibition of triglyceride secretion in fasted 
rats, indicating that its effect was primarily on the 
liver (Table  IV).  It seemed of interest to compare 
the  action of yet another "mitotic spindle" inhibi- 
tor,  i.e.,  vinblastine,  on  the  secretion  of  serum 
triglyceride.  As  seen  in  Tables  V  and  VI  the 
TABLE Ill 
Duration  of the Effect of Colchicine  on  the Secretion  of Serum  Triglycerides 
Serum lipids, percent of control* 
Duration of 
experiment  [t'C]Lipid  Triglyceride  [~'C]Lipid  Triglyceride 
rain 
Colchicine  0.05 mg/100 g body weight  0.5 mg/100 g body weight 
150  69.0  ±  6.0  61.3  ±  5.5  44.6 4- 2.3  51.7 ±  0.6 
210  56.7  4- 6.0  50.8  4- 3.4  --  -- 
270  30.6  4-  1.5  40.6 ±  4.6  17.6 ±  5.5  35.9 ±  3.7 
330  40.9  ± 4.8  53.8  4- 4.0  --  -- 
390  58.8  ±  8.0  68.6  ±  2.6  --  -- 
450  69.2  4-  10.0  80.2  ±  6.8  10.3 4-  1.3  17.2 ±  3.3 
Colchicine  was  injected  intraperitoneally  at  time  0  and  [1-1*C]palmitic  acid  and  Triton  WR  1339 were  injected 
intravenously 90 min before the termination of the experiment. Values are means 4-  SE of five to six female rats. 
* in control groups of rats used for each time interval studied, the ["C]lipid released into the serum ranged between 
43.8  ±  1.31 and 53.6  4-  1.10% of the liver +  serum pool (as in Table 1), and serum triglyceride levels ranged between 
816  4-  10 and 937  4-  30 mg/dl. 
TABLE IV 
Effect of Colchicine  on Secretion  of Serum  Triglycerides  in Fasted Rats 
Serum lipids 
Colchicine 
per 100 g  ["C]Lipid  Triglyceride 
body weight  released*  Change  Content  Change 
mg  %  %  mg/dl  % 
None  45.9 4- 3.9  713 ±  30 
0.05  17.5 +  2.1  -61.9  326 +  16  -54.3 
The rats were fasted  for  16  h  and  colchicine  was injected  intraperitoneally at time 0 and  [l-*4C]palmitic acid  and 
Triton WR  1339 were injected intravenously at 180 min and the rats were killed  at 270 min. Values are means ±  SE of 
five to six female rats. 
* As in Table I. 
TABLE V 
Effect of Vinblastine  on Secretion  of Serum  Triglycerides 
Serum lipids 
Vinblastine 
per 100 g  ["C]Lipid  Triglyceride 
body weight  released*  Change  Content  Change 
mg  %  %  mg/dl  % 
None  47.5  ± 4.1  819 +  57 
0.1  39.2  ±  1.9  -  17.5  657 +  62  -  19.5 
1.0  25.4 +  1.5  -46.6  351  ±  24  -57.2 
Vinblastine was injected  at  time 0  and  [l-"C]palmitic acid  and Triton WR  1339 were injected  at 90 min and the 
experiment was terminated at  180 min. Values are means +  SE of five to six female rats. 
* As in Table I. 
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ited  to  a  much  lesser extent,  and  the  inhibition 
required  a  higher  dose  of  vinblastine  than  of 
colchicine, which were compared on an equimolar 
basis.  The  duration  of action  of vinblastine was 
also shorter than that of colchicine and the inhibi- 
tion was almost completely reversed by 270 rain. 
To  study the secretion of the protein moiety of 
serum lipoproteins, colchicine-treated and control 
rats were injected with labeled leucine and killed 60 
rain thereafter. Results of a  representative experi- 
ment are  shown in Table  VII,  and  it can be seen 
that  while the  amount  of label  incorporated into 
the sum of liver and serum proteins was similar in 
both groups of rats, the percent of labeled protein 
in  the  circulation  was  markedly  reduced  in  the 
colchicine-treated rats.  The  protein  bound serum 
radioactivity was further characterized by separa- 
tion into distinct classes of lipoproteins. Results of 
two  representative experiments  are  presented  in 
Table  VIII.  Since  no  Triton  was  used  in  these 
experiments, the  concentration  of the  protein  in 
the various serum fractions examined reflects their 
rate of turnover. Injection of colchicine resulted in 
a  marked fall in serum levels of VLDL protein but 
in a  much lesser fall in serum HDL protein, while 
the concentration of protein in the d> 1.21 fraction 
did not change. The inhibition of release of newly 
synthesized protein  was evident in  all  the  serum 
fractions examined, as  seen  in  the fall  in  specific 
activity of the isolated proteins. The fall in specific 
activity in each class, relative to untreated control 
(rats),  was  highest  in  the  d  >  1.21 fraction,  the 
labeled protein of which consists mainly of serum 
albumin (21). 
In  the  next  series  of experiments the effect of 
colchicine  on  the  rate  of  bile  production  and 
secretion  of  phospholipid  and  cholesterol  was 
examined. Since the  rats  bad  undergone laparot- 
omy, the drug was administered intravenously. In 
TABLE VI 
Duration  of the Effect of Vinblastine  on  the 
Secretion  of Serum  Triglyeerides 
Duration of  Serum [l'C]lipids 
experiment  (percent of control) 
rain 
150  74.5 ± 5.9 
180  81.5 ± 6.5 
210  81.6 ± 6.6 
270  92.4 ± 7.8 
Vinblastine (0.1 mg/100 g body weight)  was injected at 
time 0  and  [l-14C]palmitic  acid  and  Triton  WR  1339 
were  injected  90  min  before  the  termination  of  the 
experiment. Values are means ±  SE of five to six female 
rats. 
TABLE VII 
Incorporation  of[aH]Leucine  into Liver and Serum 
Proteins  in Colchicine-Treated  Rats 
[all]Protein in liver  [~H]Protein 
Treatment  (L) + serum (S)  released* 
dpm x  10  ~  % 
None  1,287 ± 51  29.6 +  1.1 
Colchicine  1,394 ± 74  12.5 ±  1.4 
Female rats were injected  with colchicine  (0.5 mg/100 g 
body weight)  at time 0 and with [3H]leucine at  180 min 
and the experiment was terminated at 240 rain.  Values 
are means ±  SE of five to six rats. 
S 
*  x  100. 
L+S 
TABLE Vlll 
Effect of Colchicine  on Protein Content and Specific Activity of Serum Fractions  Separated by Flotation 
Protein in serum fractions  Specific  activity  of protein in 
HDL  HDL 
VLDL  (d 1.085-  VLDL  (d 1.085- 
Treatment  Exp.  (d < 1.006)  1.21)  d > 1.21  (d < 1.006)  1.21)  d > 1.21 
mg/dl  mg/dl  g/dl  dpm/mg × 10 -3 
None  I  6.0  42  4.3  49  9.9  1.5 
Colchicine  I  1.2  32  4.6  26  4.4  0.5 
None  II  7.4  38  3.9  58  20.0  2.8 
Colchicine  II  1.5  24  4.0  27  9.5  0.9 
Colchicine 0.5 mg/i00 g body weight was injected intraperitoneally at time 0 and [SH]leucine (intravenously) at  180 
min; serum was drawn at 240 min; sera from 20 female rats were pooled in each experiment. 
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Bile Flow, Phospholipid, and Cholesterol Secretion in Normal and Colchicine-Treated Rats 
Lipid phosphorus  Cholesterol 
Treatment  Time  Bile flow  in 2 h bile  in 2 h bile 
h  ml  ~g  %  #g  % 
None  0-2  1.65 ± 0.07  136 ±  11.2  100  404 ±  39.5  100 
Colchicine  2-4  1.60 ± 0.06  122 ±  14.2  89.7 ±  10.4  402 ±  57.2  99.5 ±  14.2 
Colchicine  4-6  1.41 ± 0.09  87 ±  15.8  64.0 ±  11.6  297 ±  33.0  73.5 ± 8.2 
None  0-2  1.70 ± 0.1  159 ±  14.5  100  413 ± 57.2  100 
None  2-4  1.75±0.1  115±6.1  72.3±3.8  347±21.4  84.0±5.2 
None  4-6  1.67 ± 0.1  81  ± 6.2  50.9 ±  3.9  258 ± 21.0  62.5 ±  5.1 
Bile ducts were cannulated at time 0. Colchicine (0.2 mg/100 g body weight) was injected intravenously at 2 h and the 
experiment was terminated 4 hr after injection of colchicine.  Values are means ± SE of seven to eight female rats per 
group. 
all  animals  the  first  2-h  collection  period  was 
considered  as  100%  base  line,  and  the  data  ob- 
tained  in  the subsequent  two periods were related 
to this base line. Even though a relatively high dose 
(0.2  mg/100  g  body  weight) was  used,  colchicine 
did  not  change  appreciably  the  rate  of bile  flow 
during the two periods of collection extending over 
4  h  (Table  IX).  Secretion  of  phospholipid  and 
cholesterol was reduced in the last 2-h period (4  6 
h  from  the  start  of  bile  collection),  but  this 
reduction was even slightly more prominent in the 
uninjected  controls.  Thus  it  seems that  colchicine 
administration  did not affect the secretion of lipids 
into the bile. 
Ultrastructural Findings 
After injection of 0.5 (Fig.  1) or 0.05  mg/100 g 
body weight (Figs. 2 and 3), the general ultrastruc- 
ture  of the  hepatocytes  remained  well preserved, 
and  in  some  cells a  number  of cytoplasmic  lipid 
droplets  was  also  seen  (Fig.  1).  The  prominent 
finding was the accumulation of secretory vesicles 
containing  nascent  VLDL  particles.  The  Golgi 
apparatus  was  also  filled  with  the  particles,  and 
many of the vesicles were seen in the Golgi region. 
Even though some of the vesicles were seen also in 
the  vicinity of the sinusoidal  cell surface  (Figs.  3 
and 4) there were few or no VLDL particles in the 
space of Disse, while they were quite numerous in 
control livers (Fig. 5). The particle-filled secretory 
vesicles  reached  quite  large  dimensions  and  in 
some regions they appeared  in close proximity to 
one  another  (Fig.  6).  Small  vesicles,  also  of the 
coated  variety,  were  seen  in  the  proximity  of the 
secretory  vesicles, some of which contained part±- 
cles that  have lost their distinct contours (Fig.  6). 
Secondary  lysosomes  with  electron-opaque  mate- 
rial were  often  seen in the vicinity of such collec- 
tions of secretory vesicles as shown in Fig. 6. These 
findings  might  suggest  increased  intracellular 
breakdown  of secretory lipoproteins in the face of 
inhibition  of normal  release  into  the  circulation. 
Whether  the  inhibition  of  lipoprotein  release  by 
colchicine was mediated through  its action on the 
microtubular system was difficult to determine. In 
the  normal hepatocyte,  microtubules are not very 
numerous  but  can  usually  be  demonstrated  with 
relative  ease  (Fig.  7).  They  were  much  more 
difficult  to  find  in the colchicine-treated  livers in 
which  bundles  of  microfibrils  were  frequently 
observed  in  the  vicinity  of  clusters  of  secretory 
vesicles (Fig. 8).  After incubation  of liver slices in 
the  presence  of vincristine  or vinblastine,  typical 
microcrystalline structures were seen only in Kupf- 
fer cells (Fig. 9), while in the hepatocytes the only 
pertinent  finding were bundles composed of fibril- 
lar material (Fig.  10). 
DISCUSSION 
Serum  VLDL  are  among  the  main  secretory 
products of the liver cell, and their identification in 
the  hepatocyte  has  been  well documented  (1-3). 
Their intracellular transport  has been traced from 
the  site  of  their  synthesis  in  the  endoplasmic 
reticulum, through the Golgi apparatus  and secre- 
tory vesicles to  the sinusoidal  cell surface,  and  to 
the  space  of Disse (1). The transport  to the Golgi 
apparatus  appears  to  be energy dependent,  and  is 
interrupted  after  injection  of  ethionine,  which 
causes  a  marked  fall  in  cellular  ATP  (22).  The 
STEIN,  SANGER,  AND  STEIN  Colchicine-lnduced Inhibition of tipoprotein  95 FIGURE  1  Section  of rat  liver 4  h  after injection of colchicine (0.5  mg/100  g  body weight). There  are 
numerous secretory vesicles containing nascent VLDL particles (arrows).  ×  20,000. 
FIGURE  2  Section of rat liver 3 h after injection of colchicine (0.05 mg/100 g body weight) showing Golgi 
apparatus (G) and secretory vesicles filled with nascent VLDL particles.  ×  31,000. FIGURES  3  and  4  Sections of rat liver 4 h  after injection of colchieine 0.05 (Fig. 3) or 0.5 mg/100 g body 
weight  (Fig.  4)  showing  secretory  vesicles  containing  nascent  VLDL  particles  in  the  proximity  of the 
sinusoidal cell surface and lack of particles in the space of Disse. Fig. 3,  ×  20,200;  Fig. 4,  x  37,500. 
FIGURE  5  Section of control liver showing VLDL particles in the space of Disse.  x  46,000. FIGURE  6  Section  of rat  liver 4  h  after  injection  of colchicine (0.5  mg/lO0 g  body weight). A  group of 
secretory vesicles in close proximity to each other. Nearby are seen small vesicles and a secondary lysosome 
(L).  In one of the vesicles (arrow),  the particles have lost their distinct outlines,  x  39,000. 
FIGURE  7  Section of control rat liver showing two microtubules (t).  ×  51,500. 
FIGURE  8  Section  of rat  liver 4  h  after  injection  of colchicine (0.5  mg/lO0 g  body weight). A  group of 
microfilaments (J)  is seen in the vicinity of secretory vesicles,  x  62,000. FIGURES  9 and  10  Sections of rat liver  slices  incubated with  10  5 M vinblastine (Fig. 9) and with 10  5 M 
vincristine (Fig.  10). In Fig. 9 there are microcrystalline formations in the Kupffer cell (arrows). ×  31,000.  In 
Fig.  10,  bundles of fibrillar material are seen in the cytoplasm of a hepatocyte.  ×  62,000. results obtained with  colchicine and vinblastine in 
the intact rat and with colchicine and vincristine in 
perfused mouse liver (5, 6) support the possibility 
that intact microtubules might be required for the 
operation of the final steps  of the secretory cycle. 
In the present study this hypothesis, concerning 
the  regulation of secretory processes in the liver, 
was tested  in the intact animal rather than in an 
isolated  organ.  Such  an approach  has  its  advan- 
tages by providing more physiological conditions, 
but requires certain additional controls, not neces- 
sary  for  the  in  vitro  system.  Since,  in  order  to 
measure the rate of triglyceride secretion, use was 
made  of  Triton  WR  1339 which  was  shown  to 
cause  a  linear increase in  serum  triglycerides by 
preventing their removal from the circulation (20), 
it was important to show that colchicine acts also 
in  non-Triton-treated rats.  The  second  problem 
posed by the intact animal was that, in addition to 
the  liver,  the  intestine  as  well  may  contribute 
triglyceride to the circulation. However, since the 
inhibitory effect of colchicine on triglyceride secre- 
tion was similar in fed and fasted rats (Tables I and 
IV), and since in the latter the intestine has been 
shown  to  contribute  only  about  10%  of  serum 
triglyceride (23),  it seems plausible that the effect 
of colchicine was derived primarily by its action on 
the liver. This is supported also by the finding that, 
90 min after injection of Triton, there were 56 mg 
of  triglyceride  in  8  ml  of  serum  (4%  of  body 
weight)  in  the  controls  and  only  25  mg  in  the 
colchicine-treated rats (Table IV), and thus 30 mg 
less triglyceride were delivered into the circulation 
as a  result of colchicine treatment. Under fasting 
conditions the triglyceride secreted by the intestine 
is derived mainly from hydrolyzed bile phospho- 
lipid (24),  and under our experimental conditions 
the amount of phospholipid derived from the bile 
during 90 min could provide not more than 3 mg of 
triglyceride  (Table  IX).  Thus  it  seems  that  the 
major  part  of  the  missing triglyceride  was  due 
mainly to the lack of secretion of hepatic triglycer- 
ide. There was an accumulation of the nonsecreted 
triglyceride in the  liver cell  inside secretory vesi- 
cles. This contributed towards the finding that the 
degree of inhibition of secretion by coichicine was 
higher when expressed as percent release of labeled 
triglyceride, rather than as serum levels of chemi- 
cally determined triglyceride (Table Ill). 
The main advantage of the intact animal system 
was that enough serum could be obtained to study 
the effect of colchicine on the secretion of different 
serum lipoproteins and to  deal  with the question 
whether the final steps of secretion of HDL and of 
albumin into the serum are regulated in the same 
manner as those of VLDL secretion. While nascent 
VLDL have been visualized in the Golgi apparatus 
(I-3), isolated, and defined by cheinical and immu- 
nochemical methods (25, 26), the presence of HDL 
in the Golgi apparatus has been supported mainly 
by  immunochemical  means  (27).  Studies  with 
orotic acid have indicated that  HDL secretion by 
the liver might be independent of VLDL secretion, 
the latter being inhibited to a much larger extent 
(28).  However,  interference with VLDL  secretion 
by orotic acid occurs before the Golgi apparatus, 
as evidenced by the accumulation of liposomes in 
the cisternae of the endoplasmic reticulum (29, 30). 
The  localization of the  intrahepatic precursor of 
serum  albumin in the  Golgi  apparatus  was  first 
suggested  by  Bruni  and  Porter  (31)  and  has 
obtained  support  by  the  studies  of  Ashley  and 
Peters (32) and Glaumann and Ericsson (33). Our 
present findings indicate that the final pathways of 
intracellular  transport  and  secretion  of  VLDL, 
HDL, and most probably serum albumin (present 
in the d  >  1.21 fraction) are subject to a common 
regulatory  mechanism? The  interruption of  the 
final steps of secretion resulted in the  accumula- 
tion  of  the  secretory  vesicles,  which  were  seen 
throughout the  cytoplasm of the  liver cell,  but it 
still remains to  be  shown whether all three prod- 
ucts  are  present  in  the  same  vesicle,  or  are 
segregated  among different vesicles.  It seems im- 
portant to point out that the maximal decrease in 
specific activity observed in the d  > 1.21 fraction 
was  not  due  to  a  preferential  inhibition of  its 
release, but rather to the dilution of newly secreted 
labeled molecules in a  pool of albumin, the t,j, of 
which is about 3 days (35) as compared to 10 h for 
HDL (36) and several minutes for VLDL (37). One 
of  the  theories  proposed  for  the  role  of  mi- 
crotubules in the secretory process was that these 
organelles act  as guidelines for the  movement of 
the  secretory  vesicles  towards  the  plasma  mem- 
brane (38).  The present finding of secretory vesi- 
cles in the vicinity of the plasma membrane could 
suggest  that  colchicine treatment  interfered with 
Recently, accumulation of albumin in liver slices after 
vinblastine and colchicine treatment  was  described by 
Redman (34). 
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with  its  transport  towards  the  secretory  pole. 
However, one cannot  rule out the possibility that 
colchicine has  interfered  with the  regulation  of a 
random migratory process, which might depend in 
part  on  microtubules to provide pathways for the 
secretory vesicles. If one may extrapolate from the 
data  on  Tetrahyrnena  to the liver cell, one could 
envisage that  fusion  of the  secretory vesicle with 
the plasma membrane can occur at certain specific 
recognition sites (39).  Ukena and  Berlin (40) have 
shown  that  in  polymorphonuclear leukocytes and 
macrophages  the  cell surface  operates  as  a  func- 
tional mosaic in which specific transport  sites are 
separated  from  those parts  of the membrane that 
are  usually  internalized  by  phagocytosis.  This 
topographic separation  was no longer demonstra- 
ble after treatment with colchicine and vinblastine 
(40).  These agents inhibited also the agglutination 
of polymorphonuclear leukocytes by concanavalin 
A (41). Since agglutination seems to be related to a 
certain  distribution  of  specific  sites  on  the  cell 
surface, it was suggested that these sites assume a 
more homogeneous distribution  in the absence of 
normal  microtubular  function  (41).  These  results 
would  indicate  that  the  function  of  the  mi- 
crotubules  in  the  secretion  of  lipoproteins  and 
proteins  from  the  liver  is  related  to  the  mainte- 
nance  of the  specific organization  of the  plasma 
membrane  which  is  mandatory  for  the  normal 
process  of fusion  between  the  membranes  of the 
secretory vesicles and the plasma membrane. One 
should  also consider the possibility that the inter- 
ference  with  the  release  of the  secretory product 
could  be  due  to  colchicine  binding  to  cellular 
membranes as has been recently shown by Stadler 
and  Franke  (42).  It  seems  of  interest  that,  by 
analogy  to  the  findings  in  hamster  kidney  fibro- 
blasts (43),  the loss of microtubules was accompa- 
nied by an apparent increase in microfilaments in 
the  hepatocytes  of colchicine-treated rats  and  in 
liver slices incubated  with vincristine. 
Our results concerning the change in the rate of 
secretion of phospholipid and cholesterol into the 
bile with  time of cannulation  agree with those of 
Baxter  (24).  The present  study  has  also provided 
some new insight concerning the  secretion of bile 
phospholipid  and  cholesterol.  The  studies  per- 
formed so far did not provide information as to the 
ultrastructure  of  the  precursor  pool  of  biliary 
phospholipid,  the  site  of  synthesis  of  which  has 
been  localized to the endoplasmic reticulum (17). 
Even though flattened disks, composed of a bilayer 
and  probably  corresponding  to  cholesterol-leci- 
thin-bile acid micelles, have been demonstrated in 
the  bile  (44),  such  structures  were  not  identified 
within the hepatocytes, even in biliary obstruction 
(45).  The  finding  that  colchicine did  not  inhibit 
secretion  of  lecithin  or  cholesterol  into  the  bile 
adds  support to the concept that biliary lipids are 
not  secreted  in  the  form  of particles or granules 
carried  to  the  secretory  surface  in  membrane- 
bounded  vesicles. This is  in  good  agreement  also 
with  the  lack  of  inhibition  by  colchicine  and 
vinblastine of steroid  secretion from  adrenocorti- 
cal tumor cells in culture, which apparently is also 
not released in the form of secretory granules (46). 
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Note  Added in  Proof." After this manuscript  was sub- 
mitted for publication, additional evidence for the direct 
action of colchicine on the mobility of membrane com- 
ponents  was presented for the  Tetrahymena.  (Wunder- 
lich, F., R. MUller, and V. Speth.  1973. Direct evidence 
for  a colchicine-induced impairment  in the mobility of 
membrane  components.  Science  (Wash.  D.  C.).  182: 
1136-1138.) 
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